Search for new products by date added, alphabetically, or by pharmacological action.
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the New symbol.
If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.
| Cat No | Product Name / Activity | Date Added |
|---|---|---|
| 6468 | Thalidomide - linker 2 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6494 | Galangin | Apr 2018 |
| TRPC5 inhibitor; also induces autophagy | ||
| 6465 | VH 032 - linker 3 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a short alkyl linker | ||
| 6467 | Thalidomide - linker 1 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6464 | VH 032 - linker 2 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6463 | VH 032 - linker 1 | Apr 2018 |
| Functionalized VHL ligand for PROTACs; incorporates an E3 ligase ligand plus a PEG linker | ||
| 6455 | Tocriscreen Plus Micro | Apr 2018 |
| A library of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | ||
| 6438 | BRD 6989 | Apr 2018 |
| Cdk8 inhibitor; enhances IL-10 production | ||
| 6469 | Thalidomide - linker 3 | Apr 2018 |
| Functionalized cereblon ligand for PROTACs; incorporates an E3 ligase ligand plus a short alkyl linker | ||
| 6416 | CM 11 | Apr 2018 |
| Homo-PROTAC for self-degradation of pVHL30 | ||
| 6417 | CMP 98 | Apr 2018 |
| Negative Control for CM 11 | ||
| 4647 | GR 203040 | Apr 2018 |
| Potent, selective NK1 receptor antagonist | ||
| 6409 | A 1210477 | Apr 2018 |
| Selective, high affinity Mcl-1 inhibitor; proapoptotic | ||
| 6515 | (D)-PPA 1 | Apr 2018 |
| PD-1/PD-L1 interaction inhibitor | ||
| 3649 | CP 122721 hydrochloride | Apr 2018 |
| High affinity NK1 receptor antagonist | ||
| 6435 | ML 323 | Apr 2018 |
| Potent and selective USP1-UAF1 allosteric inhibitor | ||
| 6392 | B02 | Apr 2018 |
| RAD51 recombinase inhibitor | ||
| 5730 | A 127722 | Mar 2018 |
| Highly potent, selective ETA antagonist; orally bioavailable | ||
| 6462 | VH 032, amine hydrochloride | Mar 2018 |
| Functionalized VHL ligand for PROTACs | ||
| 6410 | Tipifarnib | Mar 2018 |
| Potent farnesyltransferase inhibitor; orally bioavailable | ||
| 6241 | Biotinyl Tyramide | Mar 2018 |
| Reagent widely used for signal amplification in IHC and ISH | ||
| 6344 | OUL 35 | Mar 2018 |
| Selective PARP-10 inhibitor | ||
| 6466 | TC E3 5031 | Mar 2018 |
| Functionalized cereblon ligand for PROTACs | ||
| 6411 | tBPC | Mar 2018 |
| Postitive allosteric modulator of NPY Y4 receptor | ||
| 6300 | Azido-Thalidomide | Mar 2018 |
| Click-functionalized thalidomide | ||
| 6450 | Cortagine | Mar 2018 |
| Potent and selective CRF1 agonist | ||
| 6133 | NVS PAK1 C | Mar 2018 |
| Negative control of NVS PAK1 1 (Cat. No. 6132) | ||
| 6249 | Givinostat hydrochloride | Feb 2018 |
| Histone deacetylase inhibitor | ||
| 6431 | Phentolamine Mesylate | Feb 2018 |
| Adrenergic α receptor antagonist; antihypertensive | ||
| 6356 | AT 1 | Feb 2018 |
| (+)-JQ1 based PROTAC with selectivity for BRD4 | ||
| 6341 | INF 39 | Feb 2018 |
| Irreversible NLRP3 inhibitor | ||
| 5815 | SCH 336 | Feb 2018 |
| Highly potent and selective CB2 inverse agonist | ||
| 6242 | AG 205 | Feb 2018 |
| Progesterone receptor membrane component 1 (Pgrmc1) ligand | ||
| 6118 | 1S,3R-RSL3 | Jan 2018 |
| Induces ferroptosis; inhibits glutathione peroxidase 4 (GPX4) | ||
| 6382 | MAIT 203 | Jan 2018 |
| APC-Asef interaction inhibitor | ||
| 6419 | Janelia Fluor® 635, SE | Jan 2018 |
| Cell permeable red fluorescent dye; supplied as NHS ester | ||
| 6418 | Janelia Fluor® 585, SE | Jan 2018 |
| Cell permeable fluorescent dye; supplied as NHS ester | ||
| 5920 | LG 100268 | Jan 2018 |
| Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers | ||
| 6420 | Janelia Fluor® 669, SE | Jan 2018 |
| Cell permeable fluorescent dye; supplied as NHS ester | ||
| 6140 | NS 6784 hydrochloride | Jan 2018 |
| α7 nAChR agonist | ||
| 6358 | Atovaquone | Jan 2018 |
| Inhibits complex III of mitochondrial electron transport chain in parasites | ||
| 6280 | FIN 56 | Jan 2018 |
| Ferroptosis activator | ||
| 1993 | Halofuginone hydrobromide | Jan 2018 |
| High affinity competitive prolyl-tRNA synthetase inhibitor | ||
| 5123 | BMX-IN-1 | Jan 2018 |
| Potent and irreversible BMX inhibitor | ||
| 6069 | BMS 605541 | Jan 2018 |
| Potent VEGFR-2 inhibitor | ||
| 6423 | Pep 2-8 | Jan 2018 |
| Potent PCSK9 inhibitor | ||
| 6442 | Gentamicin sulfate | Jan 2018 |
| Aminoglycoside antibiotic | ||
| 6377 | DIM-C-pPhOH | Jan 2018 |
| Nur77 antagonist | ||
| 5922 | CRT 0066854 hydrochloride | Dec 2017 |
| PKCι and PKCζ inhibitor | ||
| 6390 | SAG dihydrochloride | Dec 2017 |
| Dihydrochloride salt of SAG; Smo receptor agonist | ||
| 6187 | SK 216 | Dec 2017 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | ||
| 5426 | SNAP 398299 | Dec 2017 |
| Potent and selective GAL3 antagonist | ||
| 6424 | Sodium Cromoglicate | Dec 2017 |
| Promotes ESCs/iPSCs differentiation into pancreatic endocine islet cells | ||
| 6125 | TC JL 37 | Dec 2017 |
| Potent TYK2 inhibitor | ||
| 6318 | Azimilide dihydrochloride | Dec 2017 |
| Kv11.1 (hERG) channel blocker | ||
| 6394 | Peptide5 | Dec 2017 |
| Connexin43 mimetic peptide | ||
| 5969 | (R)-CE3F4 | Dec 2017 |
| Epac inhibitor | ||
| 6055 | SPT Imidazopyridine 1 | Dec 2017 |
| Potent serine palmitoyl transferase inhibitor | ||
| 6376 | DIM-C-pPhOCH3 | Dec 2017 |
| Nur77 agonist | ||
| 6350 | PF 05190457 | Dec 2017 |
| High affinity and selective ghrelin receptor inverse agonist | ||
| 6248 | EHop 016 | Dec 2017 |
| Rac inhibitor | ||
| 6407 | Fendiline Hydrochloride | Dec 2017 |
| K-Ras inhibitor; inhibits K-Ras localization to the plasma membrane | ||
| 6359 | Nelarabine | Dec 2017 |
| Purine nuceloside analog; inhibits DNA synthesis | ||
| 5274 | BMS 564929 | Nov 2017 |
| Highly potent and muscle-selective androgen receptor (AR) agonist | ||
| 6096 | UNC 3866 | Nov 2017 |
| High affinity CBX4 and CBX7 inhibitor | ||
| 6405 | PF 05180999 | Nov 2017 |
| Potent and selective PDE2A inhibitor | ||
| 6326 | Ginkgolic Acid | Nov 2017 |
| Inhibits SUMOylation by binding E1 | ||
| 6251 | L Moses dihydrochloride | Nov 2017 |
| High affinity and selective PCAF bromodomain inhibitor | ||
| 3637 | Salinomycin sodium salt | Nov 2017 |
| Antibiotic; also selectively inhibits cancer stem cells | ||
| 6134 | T 26c disodium salt | Nov 2017 |
| Highly potent and selective MMP13 inhibitor | ||
| 5334 | TH 588 | Nov 2017 |
| Potent MTH1 inhibitor | ||
| 5706 | BAY 678 | Nov 2017 |
| Potent and selective cell-permeable human neutrophil elastase (HNE) inhibitor | ||
| 6366 | Muramyl Dipeptide | Nov 2017 |
| Activates NOD2 receptors | ||
| 6222 | PFM 01 | Nov 2017 |
| MRE11 endonuclease inhibitor | ||
| 6384 | Ciclopirox | Nov 2017 |
| Pan-histone demethylase inhibitor | ||
| 6389 | BAY 677 | Nov 2017 |
| Inactive control for BAY 678 (Cat.No.5706) | ||
| 5733 | ML 311 | Nov 2017 |
| Inhibits Mcl-1-BIM interaction | ||
| 5891 | TES, free acid | Nov 2017 |
| Buffering agent | ||
| 6024 | PF 04671536 hydrochloride | Nov 2017 |
| Potent and selective PDE8B/8A inhibitor | ||
| 5886 | HEPPSO | Nov 2017 |
| Buffering agent | ||
| 5884 | DIPSO | Nov 2017 |
| Buffering agents | ||
| 5875 | MES sodium salt | Nov 2017 |
| Buffering agent | ||
| 6337 | Sulopenem | Nov 2017 |
| Penem antibiotic | ||
| 6332 | Atosiban | Nov 2017 |
| Potent oxytocin receptor antagonist | ||
| 6182 | Pimonidazole | Nov 2017 |
| Hypoxia detection reagent | ||
| 6385 | Phenanthroline | Nov 2017 |
| Enhances hPSC differentiation into cranial placode cells | ||
| 6357 | Ciclesonide | Nov 2017 |
| Glucocorticoid antiasthmatic prodrug | ||
| 6195 | SSR 149415 | Nov 2017 |
| Potent and selective vasopressin V1B antagonist | ||
| 5883 | CHES | Nov 2017 |
| Buffering agent | ||
| 6414 | Rupintrivir | Nov 2017 |
| Potent and selective irreversible human rhinovirus 3C protease inhibitor | ||
| 6373 | PF 06650833 | Nov 2017 |
| Potent and selective IRAK4 inhibitor | ||
| 6343 | Rosuvastatin calcium | Nov 2017 |
| Potent HMG-CoA reductase inhibitor | ||
| 6374 | PF 04457845 | Nov 2017 |
| Potent and selective irreversible FAAH inhibitor | ||
| 6333 | Phosphoramidon disodium salt | Nov 2017 |
| Neutral endopeptidase and endothelin converting enzyme inhibitor | ||
| 6298 | MS 21570 | Nov 2017 |
| GPR171 antagonist | ||
| 6132 | NVS PAK1 1 | Oct 2017 |
| Potent and selective PAK1 inhibitor | ||
| 6035 | (S)-C33 | Oct 2017 |
| Potent PDE9 inhibitor | ||
| 6348 | PF 06424439 | Oct 2017 |
| Potent and selective DGAT2 inhibitor |